Active substanceHypromellose + DextranHypromellose + Dextran
Similar drugsTo uncover
Dosage form: & nbspeye drops
Composition:
per 1 ml of the drug:
active components:
hypromellose-3.00 mg; dextran-70-1.00 mg;
auxiliary components:
glycerol - 2.00 mg; boric acid - 3.00 mg; sodium tetraborate decahydrate - 0.35 mg; potassium chloride - 1.20 mg; sodium chloride - 6.20 mg; disodium edetate dihydrate-0.50 mg; benzalkonium chloride - 0.075 mg; 1M sodium solution hydroxide or 1M hydrochloric acid solution to pH 7.4 ± 0.1; purified water - up to, 1 ml = 1,00645 g
Description:

A clear, colorless solution.

Pharmacotherapeutic group:keratoprotective agent
ATX: & nbsp

S.01.X.A   Other drugs for the treatment of eye diseases

S.01.X.A.20   Artificial tears and other indifferent drugs

Pharmacodynamics:
The teardrop is an artificial tear, improves the hydration of the cornea, the stability of the tear film on the surface of the cornea increases.
The teardrop contains a water-soluble polymer system that, in combination with the natural tear fluid in the eye, improves the hydration of the cornea, providing the hydrophilicity of the corneal surface due to the usual adsorption processes at the interface of the tear film and the surface of the cornea.The drug is physiologically mixed with a film of tear fluid, increasing its stability on the surface of the cornea. Reduces irritation symptoms associated with dry eye syndrome, and protects the cornea from drying out. After a single instillation, the drug remains for 90 minutes.
Pharmacokinetics:Hypromellose has a large molecular weight (86,000 Daltons) and is therefore absorbed slowly. Hypromellose is a metabolically inert material.
Indications:

Syndrome of "dry eye".

Contraindications:
Hypersensitivity to hypromellose, dextran or any component of the drug.
Children under 18 years of age (there are no data on the possible use of the drug in children.
Pregnancy and lactation:
The use of the drug during pregnancy, and during lactation (breastfeeding) is possible only if the perceived benefit to the mother exceeds the potential risk to the fetus or child.
Adequate and strictly controlled clinical studies on the safety and efficacy of the drug during pregnancy and lactation (breastfeeding) were not conducted.
Dosing and Administration:
Locally.
1-2 drops in the conjunctival sac of each affected eye as needed several times a day or as prescribed by the doctor.
Duration of treatment, depending on the severity of the disease and is appointed by the doctor. If there is no effect, stop the instillation of the drug.
Side effects:
Infrequent (0.1 - 1%): blurred vision, a feeling of discomfort in the eyes (burning, tingling).
Rarely (0.01 - 0.1%): redness of the eyes, lacrimation, fatigue of the eyes.
Perhaps the development of allergic reactions.
Overdose:Currently, no cases of an overdose of Slezin were reported. If eye contact occurs in excess of the ophthalmic solution, eyes should be rinsed with warm water.
Interaction:Teardrop is not compatible with eye drops containing metal salts (zinc sulfate and etc.).
Special instructions:
When wearing contact lenses before instilling the drug, they should be removed and re-installed no earlier than 15 minutes after using the drug.
The drug Slezin should not be used for injections!
If after 2-3 days of using the drug there is no improvement, it is recommended to interrupt treatment.

Effect on the ability to drive transp. cf. and fur:Because of the possible blurring of vision, during the treatment period, care must be taken when driving vehicles and engaging in potentially dangerous activities that require an increased concentration of attention and speed of psychomotor reactions.
Form release / dosage:
Eye drops 3 mg / ml + 1 mg / ml.

Packaging:For 15 ml of the drug in a white polymer bottle-dropper closed with a polymer lid with a safety ring. One bottle-dropper along with instructions for use in a cardboard pack.
Storage conditions:
In the dark place at a temperature of no higher than 25 ° C.
Inaccessible to children!
Shelf life:
3 years.
After opening the bottle, the drops should be used within 4 weeks. Do not use after the expiration date!
Terms of leave from pharmacies:Without recipe
Registration number:PL-000947
Date of registration:18.10.2011
The owner of the registration certificate:K.O. Ромфарм Компани С.Р.Л.K.O. Ромфарм Компани С.Р.Л. Romania
Manufacturer: & nbsp
Representation: & nbspРомфарма ОООРомфарма ООО
Information update date: & nbsp15.12.2015
Illustrated instructions
    Instructions
    Up